Abstract
Hepatic encephalopathy (HE) includes cognitive, psychiatric and neuromotor abnormalities observed from brain dysfunction secondary to liver disease and/or porto-systemic shunting. HE can have a wide range of clinical manifestations ranging from trivial lack of awareness, decreased attention span, personality changes to confusion, seizures, coma, and death. The onset of HE in cirrhosis is a poor prognostic factor. While HE has a complex pathogenesis which is not completely understood, hyperammonemia plays an important role in neurotoxicity and brain dysfunction. Alkalemia facilitates the conversion of NH4+ to NH3, which is free to cross the blood-brain barrier exacerbating HE. Prompt recognition and correction of underlying risk factors is central to the management of HE.
References
May 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E G Lowrie, N L Lew
Jan 1, 1988·Contributions to Nephrology·A TizianelloM Bruzzone
Feb 1, 1959·The Journal of Clinical Investigation·J R STABENAUD P RALL
Jun 14, 2006·The Journal of Pediatrics·Kevin D McBrydePatrick D Brophy
Nov 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Timothy J Davern
Dec 15, 2010·Journal of Hepatology·Juan Córdoba
Apr 14, 2015·Mayo Clinic Proceedings·Elliot B TapperVilas R Patwardhan
Jun 5, 2015·Journal of Clinical and Experimental Hepatology·Narayan Dharel, Jasmohan S Bajaj
May 21, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Shruti GuptaRobert Hootkins
Oct 27, 2016·The New England Journal of Medicine·Eelco F M Wijdicks
Nov 25, 2016·Journal of the American Society of Nephrology : JASN·Matthew K Abramowitz
Jul 8, 2017·Journal of Hepatology·Bernhard ScheinerGeorg-Christian Funk
Dec 25, 2019·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Mohammad Amin Fallahzadeh, Robert S Rahimi